CGN — Cognetivity Neurosciences Cashflow Statement
0.000.00%
Last trade - 00:00- CA$1.79m
- CA$3.14m
- CA$0.05m
Annual cashflow statement for Cognetivity Neurosciences, fiscal year end - January 31st, CAD millions except per share, conversion factor applied.
2019 January 31st | 2020 January 31st | 2021 January 31st | 2022 January 31st | 2023 January 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.19 | -2.65 | -1.93 | -13.1 | -7.43 |
| Depreciation | |||||
| Non-Cash Items | 0.947 | 0.03 | 0.132 | 3.94 | 1.31 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.249 | 0.749 | -0.174 | 5.95 | 0.156 |
| Change in Accounts Receivable | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -3.49 | -1.86 | -1.96 | -3.21 | -5.94 |
| Capital Expenditures | -0.021 | -0.022 | -0.05 | -0.1 | -0.07 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 3.34 | 0.128 | 0 | — | — |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Cash from Investing Activities | 3.32 | 0.106 | -0.05 | -0.1 | -0.07 |
| Financing Cash Flow Items | 0 | — | — | — | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.299 | 2.08 | 2.79 | 3.33 | 6.88 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.112 | 0.327 | 0.782 | 0.017 | 0.867 |